Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cianfarani

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|July 9, 1994
What is the rationale for growth hormone therapy in Turner's syndrome?S Cianfarani, F Vaccaro, B Boscherini
Journal of Endocrinological Investigation|January 1, 1989
Clinical features of growth hormone (GH) deficiencyB Boscherini, S Cianfarani, G L Spadoni
Medicina (Florence, Italy)|July 1, 1988
[Growth disorders]B Boscherini, S Cianfarani, G L Spadoni
The Journal of Endocrinology|April 6, 2000
IGF-I stimulates chemotaxis of human neuroblasts. Involvement of type 1 IGF receptor, IGF binding proteins, phosphatidylinositol-3 kinase pathway and plasmin systemA Puglianiello, D Germani, P Rossi, et al.
Acta Paediatrica (Oslo, Norway : 1992)|November 1, 1995
Imperforate anus, bilateral hydronephrosis, bilateral undescended testes and pituitary hypoplasia: a variant of Hall-Pallister syndrome or a new syndromeS Cianfarani, S Vitale, R Stanhope, et al.
Metabolism: Clinical and Experimental|August 1, 1995
Is obesity-related insulin status the cause of blunted growth hormone secretion in Turner's syndrome?F Vaccaro, S Cianfarani, A M Pasquino, et al.
European Journal of Endocrinology|December 1, 1996
Do insulin-like growth factor binding proteins (IGFBPs) modulate the IGF-I growth promoting and differentiating effects in human neuroblastoma cells?S Cianfarani, D Germani, P Rossi, et al.
Journal of Endocrinological Investigation|March 26, 2008
Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient childrenG Scirè, C Del Bianco, G L Spadoni, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 7, 2016
Predictors of blood pressure at 7-13 years: The "new millennium baby" studyP Brambilla, G Bedogni, A Pietrobelli, et al.
Journal of Endocrinological Investigation|November 11, 2008
Catch-up growth in body mass index is associated neither with reduced insulin sensitivity nor with altered lipid profile in children born small for gestational ageP Torre, C Ladaki, G Scirè, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|July 9, 1994
What is the rationale for growth hormone therapy in Turner's syndrome?S Cianfarani, F Vaccaro, B Boscherini
Journal of Endocrinological Investigation|January 1, 1989
Clinical features of growth hormone (GH) deficiencyB Boscherini, S Cianfarani, G L Spadoni
Medicina (Florence, Italy)|July 1, 1988
[Growth disorders]B Boscherini, S Cianfarani, G L Spadoni
The Journal of Endocrinology|April 6, 2000
IGF-I stimulates chemotaxis of human neuroblasts. Involvement of type 1 IGF receptor, IGF binding proteins, phosphatidylinositol-3 kinase pathway and plasmin systemA Puglianiello, D Germani, P Rossi, et al.
Acta Paediatrica (Oslo, Norway : 1992)|November 1, 1995
Imperforate anus, bilateral hydronephrosis, bilateral undescended testes and pituitary hypoplasia: a variant of Hall-Pallister syndrome or a new syndromeS Cianfarani, S Vitale, R Stanhope, et al.
Metabolism: Clinical and Experimental|August 1, 1995
Is obesity-related insulin status the cause of blunted growth hormone secretion in Turner's syndrome?F Vaccaro, S Cianfarani, A M Pasquino, et al.
European Journal of Endocrinology|December 1, 1996
Do insulin-like growth factor binding proteins (IGFBPs) modulate the IGF-I growth promoting and differentiating effects in human neuroblastoma cells?S Cianfarani, D Germani, P Rossi, et al.
Journal of Endocrinological Investigation|March 26, 2008
Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient childrenG Scirè, C Del Bianco, G L Spadoni, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 7, 2016
Predictors of blood pressure at 7-13 years: The "new millennium baby" studyP Brambilla, G Bedogni, A Pietrobelli, et al.
Journal of Endocrinological Investigation|November 11, 2008
Catch-up growth in body mass index is associated neither with reduced insulin sensitivity nor with altered lipid profile in children born small for gestational ageP Torre, C Ladaki, G Scirè, et al.
Pageof 9